Literature DB >> 28803352

Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review.

M Lodi1, L Scheer2, N Reix3,4, D Heitz5, A-J Carin6, N Thiébaut7, K Neuberger7, C Tomasetto8, C Mathelin2,8,9.   

Abstract

PURPOSE: Breast cancer is the most common malignancy in women in terms of incidence and mortality. Age is undoubtedly the biggest breast cancer risk factor. In this study we examined clinical, histological, and biological characteristics and mortality of breast cancer in elderly women along with their changes with advancing age.
METHODS: We reviewed 63 original articles published between 2006 and 2016 concerning women over 70 years with breast cancer.
RESULTS: Compared to patients 70-79 years, patients aged 80 and over had larger tumor size with fewer T1 (42.9% vs 57.7%, p < 0.01) and more T2 lesions (43.5% vs 33.0%, p < 0.01). Lymph nodes and distant metastases were more frequent, with more N + (49.5% vs 44.0%, p < 0.01) and more M1 (8.0% vs 5.9%, p < 0.01). Infiltrating mucinous carcinomas were more frequent (4.3% vs 3.7%, p < 0.01). Tumors had lower grades, with more grade 1 (23.2% vs 19.8%, p = 0.01) and fewer grade 3 (21.5% vs 25.5%, p < 0.01), and were more hormone-sensitive: PR was more often expressed (72.6% vs 67.3%, p < 0.01). Lympho-vascular invasion was less frequent in the 80 years and over (22.9% vs 29.7%, p = 0.01). Breast cancer-specific mortality was higher both at 5 years (25.8% vs 17.2%, p < 0.01) and 10 years (32.7% vs 26.6%, p < 0.01).
CONCLUSION: Clinico-pathological characteristics, increased incidence, and mortality associated with aging can be explained on one hand by biological changes of the breast such as increased estrogen sensitivity, epithelial cell alterations, immune senescence, and tumor microenvironment modifications. However, sociologic factors such as increased life expectancy, under-treatment, late diagnosis, and insufficient individual screening, are also involved.

Entities:  

Keywords:  Aging; Breast cancer; Clinical characteristics; Elderly women; Pathology

Mesh:

Substances:

Year:  2017        PMID: 28803352     DOI: 10.1007/s10549-017-4448-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  22 in total

1.  Why and How Should We Improve Breast Cancer Management in Elderly Women?

Authors:  Massimo Lodi; Andrea Lodi; Nathalie Reix; Catherine Tomasetto; Carole Mathelin
Journal:  Eur J Breast Health       Date:  2018-07-01

2.  Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator.

Authors:  Helen M Johnson; William Irish; Nasreen A Vohra; Jan H Wong
Journal:  Breast Cancer Res Treat       Date:  2021-02-20       Impact factor: 4.872

Review 3.  Surgery in the Older Patient with Breast Cancer.

Authors:  Julia Frebault; Carmen Bergom; Amanda L Kong
Journal:  Curr Oncol Rep       Date:  2019-06-25       Impact factor: 5.075

4.  Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database.

Authors:  Julia Frebault; Carmen Bergom; Chandler S Cortina; Monica E Shukla; Yiwen Zhang; Chiang-Ching Huang; Amanda L Kong
Journal:  Clin Breast Cancer       Date:  2021-07-16       Impact factor: 3.225

5.  Low RUFY3 expression level is associated with lymph node metastasis in older women with invasive breast cancer.

Authors:  Fernando A Angarita; Masanori Oshi; Akimitsu Yamada; Li Yan; Ryusei Matsuyama; Stephen B Edge; Itaru Endo; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2022-01-12       Impact factor: 4.872

6.  Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age.

Authors:  Lauren M Drapalik; Jonathan J Hue; Ashley Simpson; Mary Freyvogel; Lisa Rock; Robert R Shenk; Amanda L Amin; Megan E Miller
Journal:  Ann Surg Oncol       Date:  2022-08-08       Impact factor: 4.339

7.  S-phase fraction, lymph node status and disease staging as the main prognostic factors to differentiate between young and older patients with invasive breast carcinoma.

Authors:  António E Pinto; João Matos; Teresa Pereira; Giovani L Silva; Saudade André
Journal:  Oncol Lett       Date:  2022-08-04       Impact factor: 3.111

8.  Prognostic validation and treatment decision making of the 8th edition of the American Joint Committee on Cancer pathological staging system for elderly women with early-stage breast cancer.

Authors:  San-Gang Wu; Jian Shi; Wen-Wen Zhang; Jun Wang; Chen-Lu Lian; Jian Lei; Li Hua; Juan Zhou; Zhen-Yu He
Journal:  Aging (Albany NY)       Date:  2020-07-25       Impact factor: 5.682

9.  The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes.

Authors:  Matthew Mills; Casey Liveringhouse; Frank Lee; Ronica H Nanda; Kamran A Ahmed; Iman R Washington; Ram Thapa; Brooke L Fridley; Peter Blumencranz; Martine Extermann; Loretta Loftus; Lodovico Balducci; Roberto Diaz
Journal:  J Geriatr Oncol       Date:  2020-08-26       Impact factor: 3.599

10.  Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting.

Authors:  Chiara Mandoj; Laura Pizzuti; Domenico Sergi; Isabella Sperduti; Marco Mazzotta; Luigi Di Lauro; Antonella Amodio; Silvia Carpano; Anna Di Benedetto; Claudio Botti; Francesca Ferranti; Anna Antenucci; Maria Gabriella D'Alessandro; Paolo Marchetti; Silverio Tomao; Giuseppe Sanguineti; Antonio Giordano; Marcello Maugeri-Saccà; Gennaro Ciliberto; Laura Conti; Patrizia Vici; Maddalena Barba
Journal:  J Transl Med       Date:  2018-05-16       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.